SecBot SecBot
EFFECT ·Filed Aug 11, 2026

LFWD

Lifeward Ltd.
BEARISH
Impact 7/10
Horizonweeks Processed3mo ago SEC9999999995-26-002600
IPO/offering going effective
Actionable Insight ▼ Bearish

The effectiveness of this massive resale shelf creates a persistent overhang. Traders should expect selling pressure as the selling shareholders unwind positions. Monitor for any takedown notices or Form 4 filings from Oramed and Creative Value Capital. The going-concern risk amplifies the bearish case.

DirectionBearish
Confidencehigh
Horizonweeks

How the stock moved after the report

BEARISH VIEWSTOCK BELOW ENTRY AT T+60
Entry
$7.57
T+0 close · Aug 11, 2026 · via day close
Latest settled
−19.89%
T+60 · $6.06
Vs SPY
−19.41%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Aug 11 $7.57entry
  2. T+1 · 3mo ago +2.45%α +2.19% · $7.75
  3. T+5 · 3mo ago −2.08%α −1.67% · $7.41
  4. T+20 · 2mo ago −2.18%α −1.12% · $7.40
  5. T+60 · 13d ago −19.89%α −19.41% · $6.06
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Lifeward Ltd.'s S-3 shelf registration (File No. 333-297919) became effective on August 10, 2026. This allows the company to sell up to 7,256,474 ordinary shares held by selling shareholders Oramed Pharmaceuticals and Creative Value Capital LP, representing approximately 261% of current shares outstanding. The company receives no proceeds from this resale shelf, and the massive potential overhang combined with the auditor's going-concern doubt creates a bearish overhang on the stock.

Key Facts

  • Shelf registration 333-297919 declared effective on August 10, 2026.
  • Covers 7,256,474 ordinary shares for resale by Oramed Pharmaceuticals and Creative Value Capital LP.
  • Shares represent approximately 261% of current shares outstanding.
  • Company receives no proceeds from the offering.
  • Auditor has expressed substantial doubt about going concern.

Financial Impact

Potential dilution overhang of ~261% of current shares outstanding; no proceeds to company.

dilutionshare price

Risk Factors

  • Massive dilution overhang from selling shareholders.
  • Going-concern doubt from auditor.
  • No proceeds to company, pure secondary selling.

Market Snapshot

Exchange
Nasdaq
Sector
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Analyst Consensus
88% bullish (8 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
EFFECT Filing (Primary)9999999995-26-002600
Document: 9999999995-26-002600-index.html9999999995-26-002600
Document: 9999999995-26-002600.txt9999999995-26-002600

Track record

25 reports on LFWD

Performance horizon

6 of 7 bullish or bearish reports moved the stock their way by T+5. Best: +20.27% at T+60 after the Aug 14, 2026 report. 8 of 8 went positive at some point.

Filters
  1. Nov 13, 20263d ago Press Release Bearish 6/10 Entry $4.06 Now $3.62 +10.84% settles Nov 20
  2. Nov 12, 20264d ago 3 Neutral 1/10 Entry $4.06 Now $3.62 −10.84% settles Nov 20
  3. Nov 3, 202613d ago 3 Neutral 2/10 Entry $6.06 to $5.76 Now $3.62 −40.26% ▼ −4.95% −4.04% vs SPY
  4. Oct 27, 202620d ago 8-K Neutral 2/10 Entry $6.04 to $5.83 Now $3.62 −40.07% ▼ −3.48% −1.49% vs SPY
  5. Oct 8, 20265w ago 8-K Bearish 5/10 Entry $6.49 to $6.00 Now $3.62 +44.22% ▲ +7.55% +5.58% vs SPY
  6. Oct 1, 20266w ago 8-K Neutral 2/10 Entry $5.96 to $6.43 Now $3.62 −39.26% ▲ +7.89% +6.58% vs SPY
  7. Sep 25, 20267w ago DEF 14A Bearish 7/10 Entry $6.92 to $6.67 Now $3.62 +47.69% ▲ +3.61% +4.82% vs SPY
  8. Aug 14, 202613w ago 8-K Mixed 6/10 No price data
  9. Aug 14, 202613w ago Press Release Bearish 6/10 Entry $7.45 to $7.32 Now $3.62 +51.41% ▲ +1.75% +0.38% vs SPY
  10. Aug 11, 202614w ago EFFECT Bearish 7/10 Viewing Entry $7.57 to $7.41 Now $3.62 +52.15% ▲ +2.08% +1.67% vs SPY
Showing 10 of 25

US Market Status

Market Closed · Opens in 9h 4m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 11, 2026